You are using an outdated browser. Please upgrade your browser to improve your experience.
CA125

Cherish Women's Cancer Foundation successfully gained a grant to develop this Smartphone Application to assist ovarian and endometrial (uterine) cancer patients feel more in control of their experience post-diagnosis

Cherish Women's Cancer Foundation successfully gained a grant to develop this Smartphone Application to assist ovarian and endometrial (uterine) cancer patients feel more in control of their experience post-diagnosis

CA125

by GYNAECOLOGICAL CANCER FOUNDATION LTD
CA125
CA125
CA125

What is it about?

Cherish Women's Cancer Foundation successfully gained a grant to develop this Smartphone Application to assist ovarian and endometrial (uterine) cancer patients feel more in control of their experience post-diagnosis. This App allows patients to input details given to them by their gynaecological oncologist so they can see quickly and easily progress with the tumour markers in their blood.

CA125

App Details

Version
1.0
Rating
NA
Size
8Mb
Genre
Medical Productivity
Last updated
September 6, 2017
Release date
September 6, 2017
More info

App Screenshots

CA125 screenshot-0
CA125 screenshot-1
CA125 screenshot-2
CA125 screenshot-3
CA125 screenshot-4

App Store Description

Cherish Women's Cancer Foundation successfully gained a grant to develop this Smartphone Application to assist ovarian and endometrial (uterine) cancer patients feel more in control of their experience post-diagnosis. This App allows patients to input details given to them by their gynaecological oncologist so they can see quickly and easily progress with the tumour markers in their blood.

Proceeds from the sale of this App goes to Cherish to continue its work in the ovarian cancer and endometrial (uterine) cancer space. In addition to providing much needed funding towards clinical trials into these cancer types, this App also collects non-identifying data as a valuable research tool for researchers in Australia to better design solutions for women diagnosed with ovarian and endometrial (uterine) cancer. It's this secondary benefit which is of immeasurable value to the future of research into prevention, diagnosis and treatment that can not be done without the support of such women.

We thank you for helping Cherish to achieve its goal to provide kinder ways to treat women.

Should you wish to find out more about Cherish, please visit our website www.cherish.org.au

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.